International Conference on Gene Therapy and Clinical Applications
(ICGTCA-26)

31st October 2026 || Coimbatore - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Gene Therapy and Clinical Applications (ICGTCA), scheduled to be held on 31st October 2026 in Coimbatore, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Genetics.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Gene Therapy Techniques
    This track will explore the latest methodologies in gene therapy, focusing on innovative approaches to enhance therapeutic efficacy. Discussions will include novel gene delivery systems and their implications for clinical applications. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Viral Vectors in Gene Delivery
    This session will delve into the design and optimization of viral vectors for gene therapy applications. Participants will examine case studies highlighting the successes and challenges of using viral vectors in clinical settings. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Somatic Gene Therapy: Current Trends and Future Directions
    This track will provide insights into somatic gene therapy, emphasizing its potential to treat a variety of genetic disorders. Presenters will discuss ongoing clinical trials and the regulatory landscape surrounding these therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Therapeutic Genes and Their Applications
    This session will focus on the identification and application of therapeutic genes in the treatment of genetic diseases. Researchers will present their findings on gene modulation and its impact on patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Gene Replacement Strategies in Clinical Trials
    This track will review current clinical trials involving gene replacement strategies for genetic disorders. Experts will discuss the challenges faced in translating these strategies from bench to bedside. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Molecular Medicine and Genetic Diseases
    This session will explore the intersection of molecular medicine and genetics, highlighting innovative approaches to diagnosing and treating genetic diseases. Participants will share insights on the role of molecular diagnostics in personalized medicine. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 07 – Ex Vivo and In Vivo Gene Therapy Approaches
    This track will compare ex vivo and in vivo gene therapy techniques, discussing their respective advantages and limitations. Case studies will illustrate the practical applications of both approaches in clinical settings. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 08 – Regenerative Medicine and Gene Therapy
    This session will examine the role of gene therapy in regenerative medicine, focusing on its potential to repair or replace damaged tissues. Presentations will highlight recent breakthroughs and future prospects in this rapidly evolving field. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 09 – Immunotherapy and Gene Therapy Synergies
    This track will investigate the synergistic potential of combining immunotherapy with gene therapy for enhanced therapeutic outcomes. Researchers will present data on how these approaches can work together to combat various diseases. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Genome Correction Techniques and Applications
    This session will focus on genome editing technologies and their applications in gene therapy. Experts will discuss the ethical considerations and potential regulatory challenges associated with genome correction. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 11 – Targeted Therapy and Gene Modulation
    This track will explore the principles of targeted therapy and gene modulation in the context of genetic diseases. Participants will share innovative strategies for enhancing the specificity and efficacy of therapeutic interventions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228